Cytek Biosciences to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Cytek Biosciences (Nasdaq: CTKB), a leading cell analysis solutions company, has announced its participation in several upcoming investor conferences in early 2025. The schedule includes:

• BTIG 12th Annual MedTech Conference in Snowbird, UT (February 11-12, 2025)
• Raymond James 46th Annual Institutional Investors Conference in Orlando, FL (March 3, 2025, at 3:25 PM ET)
• TD Cowen 45th Annual Health Care Conference in Boston, MA (March 5, 2025, at 10:30 AM ET)
• Leerink Partners Global Healthcare Conference in Miami, FL (March 10-12, 2025)

Live and archived webcasts for the Raymond James and TD Cowen conferences will be available on the company's investor relations website at investors.cytekbio.com.

FREMONT, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences.

• BTIG 12^th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, UT
  Participating on Tuesday, February 11 and Wednesday, February 12, 2025

• Raymond James 46^th Annual Institutional Investors Conference in Orlando, FL
  Presentation on Monday, March 3, 2025, at 3:25 p.m. Eastern Time / 12:25 p.m. Pacific Time

• TD Cowen 45^th Annual Health Care Conference in Boston, MA
  Fireside chat on Wednesday, March 5, 2025, at 10:30 a.m. Eastern Time / 7:30 a.m. Pacific time

• Leerink Partners Global Healthcare Conference in Miami, FL
  Participating on Monday, March 10 through Wednesday, March 12, 2025

Interested parties may access a live and archived webcast of the presentations at the Raymond James 46^th Annual Institutional Investors Conference and TD Cowen 45^th Annual Health Care Conference on the “Investors” section of the company website at: investors.cytekbio.com.

About Cytek Biosciences, Inc.
Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP™) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek’s platform includes its core FSP instruments, the Cytek Aurora™ and Northern Lights™ systems and its Cytek Aurora CS cell sorter; the Cytek Orion™ reagent cocktail preparation system; the Enhanced Small Particle™ (ESP™) detection technology; the flow cytometer and imaging products under the Amnis^® and Guava^® brands; and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at www.cytekbio.com.

Cytek’s products are for research use only and not for use in diagnostic procedures (other than Cytek’s Northern Lights-CLC system and certain reagents, which are available for clinical use in China and the European Union).

Cytek, Full Spectrum Profiling, FSP, Cytek Aurora, Northern Lights, Cytek Orion, Enhanced Small Particle, ESP, Amnis and Guava are trademarks of Cytek Biosciences, Inc.

In addition to filings with the Securities and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and X (formerly Twitter) account as channels of distribution of information about its company, products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Such information may be deemed material information and Cytek may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek’s website, LinkedIn page, and X account in addition to following its SEC filings, news releases, public conference calls and webcasts.

Media Contact:
Stephanie Olsen
Lages & Associates
(949) 453-8080
stephanie@lages.com

Investor Contact:
Paul Goodson
Head of Investor Relations
pgoodson@cytekbio.com

FAQ

When is Cytek Biosciences (CTKB) presenting at the Raymond James Conference in March 2025?

Cytek Biosciences will present at the Raymond James 46th Annual Institutional Investors Conference on March 3, 2025, at 3:25 PM Eastern Time.

Which investor conferences is CTKB attending in February 2025?

CTKB is attending the BTIG 12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, UT on February 11-12, 2025.

How can investors access Cytek Biosciences' (CTKB) conference presentations?

Investors can access live and archived webcasts of the Raymond James and TD Cowen conference presentations through the 'Investors' section at investors.cytekbio.com.

What time is CTKB's fireside chat at the TD Cowen Healthcare Conference?

CTKB's fireside chat at the TD Cowen 45th Annual Health Care Conference is scheduled for March 5, 2025, at 10:30 AM Eastern Time.

Which conferences will CTKB attend in March 2025?

In March 2025, CTKB will attend the Raymond James Conference (March 3), TD Cowen Healthcare Conference (March 5), and Leerink Partners Global Healthcare Conference (March 10-12).